UC San Diego study finds new compound targets brain-eating amoeba Naegleria fowleri
Researchers at UC San Diego report identifying a compound that can neutralize Naegleria fowleri, the amoeba responsible for a rare but often fatal brain infection, faster than existing treatments. The compound reportedly showed lower toxicity in lab testing compared with current drugs used against the pathogen.
GoKawiil's interpretation of the reporting above, not reported fact.
Naegleria fowleri infections are rare but kill roughly 97% of those infected, largely because existing treatments are slow and often toxic, according to the reported research. A faster, less toxic option could improve survival odds if it eventually moves from lab findings into clinical use, though further testing would be needed before any treatment reaches patients.
- UC San Diego scientists identified a new compound against Naegleria fowleri
- The compound reportedly works faster and is less toxic than current treatments
- Naegleria fowleri infections have a fatality rate of about 97%
Source: gizmodo.com, 2026-10-27
Published there as: “The Brain-Eating Amoeba Kills 97% of Its Victims. Scientists May Have Found a Way to Stop It in Hours”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.